Authors/Disclosures
|
Scott Strader, MD
(University of Colorado Health)
|
No disclosure on file |
|
Robert L. Rodnitzky, MD, FAAN
(University of Iowa)
|
No disclosure on file |
|
Pedro Gonzalez-Alegre, MD
(Spark Therapeutics)
|
Dr. Gonzalez-Alegre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Gonzalez-Alegre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Therapeutics. Dr. Gonzalez-Alegre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuExcell. The institution of Dr. Gonzalez-Alegre has received research support from NIH/NINDS. Dr. Gonzalez-Alegre has received intellectual property interests from a discovery or technology relating to health care. |
|
Ekokobe Fonkem, DO
(Medical College of Wisconsin)
|
Dr. Fonkem has received personal compensation for serving as an employee of Barrow Neurological Institute. Dr. Fonkem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Fonkem has stock in Global Cancer Technology. |